IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Protagonist Therapeutics Inc

CUSIP: 00744E106 | 3 institutional holders

Quarters

Q2 2026Q1 2026Q4 2025Q4 2020
CompareDetailedHistoricalFundsOptionsShort Interest13D/13GPeersTargetingTrading SummaryProfile

Institutional Holders — Q2 2026

Allworth Financial LP254
0.0% of portfolio›$31.1K
StyleTurnoverLocationFiled
Allworth Financial LP
254$31.1K0.0%ETFLowFolsom, CA2026-08-11